Between 2013 and 2023, the value per capita of the Hormones in Dosage market in Ecuador, excluding contraceptives and antibiotics, has shown an overall increasing trend, rising from $7.26 to $10.12. Notable growth periods include 2013-2016 and a notable increase in 2020. Recent years have seen slight fluctuations, with 2023 showing a modest recovery at $10.12 after a dip in 2022. The average compound annual growth rate (CAGR) over the last five years stands at approximately 1.33%, indicating steady market resilience with some variations.
Future trends to watch for include potential impacts from emerging health issues that might affect demand, ongoing advancements in hormone-related therapies, and international economic fluctuations that could influence Ecuador's import capacity and market prices. Additionally, regulatory changes and consumer health awareness could significantly affect market dynamics.
